Sanofi
SNY
$52.76
$0.440.84%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | 96.90% | 6.62% | -11.54% | -47.81% | |
| Total Other Revenue | -27.99% | 0.79% | 25.23% | 69.65% | |
| Total Revenue | 74.25% | 6.28% | -9.37% | -40.32% | |
| Cost of Revenue | 52.69% | 2.76% | -2.39% | -34.51% | |
| Gross Profit | 86.23% | 7.85% | -12.13% | -43.12% | |
| SG&A Expenses | 126.69% | 1.87% | -18.03% | -58.58% | |
| Depreciation & Amortization | 50.31% | -9.63% | 0.19% | -31.65% | |
| Other Operating Expenses | -40.31% | 46.57% | 17.59% | 84.95% | |
| Total Operating Expenses | 42.02% | 6.65% | -3.46% | -26.34% | |
| Operating Income | 541.65% | 4.13% | -29.90% | -122.73% | |
| Income Before Tax | 184.61% | -18.50% | -55.17% | -132.35% | |
| Income Tax Expenses | 164.82% | 9.10% | -77.06% | -133.60% | |
| Earnings from Continuing Operations | 190.58% | -23.67% | -50.17% | -131.99% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -446.51% | 67.04% | 6.00% | 106.34% | |
| Net Income | 208.99% | -23.31% | -42.51% | -121.02% | |
| EBIT | 541.65% | 4.13% | -29.90% | -122.73% | |
| EBITDA | 691.19% | 1.00% | -23.05% | -86.76% | |
| EPS Basic | 208.24% | -23.27% | -42.49% | -121.17% | |
| Normalized Basic EPS | -- | 2.80% | -- | -- | |
| EPS Diluted | 208.24% | -23.65% | -42.49% | -121.17% | |
| Normalized Diluted EPS | -- | 2.07% | -- | -- | |
| Average Basic Shares Outstanding | 0.15% | -0.05% | -0.04% | -0.18% | |
| Average Diluted Shares Outstanding | -0.22% | 0.66% | -0.04% | 0.19% | |
| Dividend Per Share | 3.23% | -- | -- | 11.29% | |
| Payout Ratio | -- | -- | -- | -- | |